WCM Investment Management
KYNB

WCM Investment Management’s Kyntra Bio KYNB Stock Holding History

WCM Investment Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,548
Closed -$1.66M – 187
2019
Q4 		$1.66M Buy
1,548
+1,188
+330% +$1.21M 0.01% 149
2019
Q3 		$333K Hold
360
– – ﹤0.01% 147
2019
Q2 		$407K Sell
360
-6
-2% -$6.57K ﹤0.01% 144
2019
Q1 		$497K Buy
+366
New +$496K ﹤0.01% 135

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

WCM Investment Management's KYNB Position: Q1 2020 in Review

WCM Investment Management sold out of Kyntra Bio (KYNB) in Q1 2020, closing a stake of 1,548 shares — an estimated $1.66M sold.

WCM Investment Management first reported a position in KYNB in Q1 2019 and held it in 4 quarters. The position peaked at $1.66M in Q4 2019. 187 funds tracked by Wall St. Rank hold KYNB as of Q1 2020.

  • WCM Investment Management reported no remaining Kyntra Bio position as of Q1 2020 after selling out during the quarter.
  • WCM Investment Management sold 1,548 Kyntra Bio shares in Q1 2020, an estimated $1.66M.
  • WCM Investment Management first reported a position in Kyntra Bio in Q1 2019 and held it in 4 quarters.
  • WCM Investment Management's Kyntra Bio position peaked at $1.66M in Q4 2019.
  • 187 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2020.

Based on WCM Investment Management's 13F filing for Q1 2020, filed 8 May 2020.